Tag: Paragraph IV certification
Tentative Approval and Patent Litigation: Navigating the Path to Generic Market Entry
Learn how tentative approval works in the US generic drug market, the role of patent litigation, and how to avoid costly delays during market entry.
Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Market Entry
Paragraph IV certifications let generic drugmakers challenge brand-name patents before launch, speeding up cheaper alternatives. This legal tool under the Hatch-Waxman Act has saved consumers trillions and reshaped pharmaceutical competition.